|
|
Volumn 20, Issue 4, 1997, Pages 469-471
|
|
The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTILIPEMIC AGENT;
DRUG DERIVATIVE;
GEMFIBROZIL;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYPOCHOLESTEROLEMIC AGENT;
MEVINOLIN;
SIMVASTATIN;
TRIACYLGLYCEROL;
BLOOD;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
DIABETIC ANGIOPATHY;
HUMAN;
MORTALITY;
MULTICENTER STUDY;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
SCANDINAVIA;
SURVIVAL RATE;
ANTICHOLESTEREMIC AGENTS;
ANTILIPEMIC AGENTS;
CHOLESTEROL, HDL;
CORONARY DISEASE;
DIABETIC ANGIOPATHIES;
GEMFIBROZIL;
HUMANS;
LOVASTATIN;
MULTICENTER STUDIES;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
SCANDINAVIA;
SIMVASTATIN;
SURVIVAL RATE;
TRIGLYCERIDES;
|
|
EID: 0031113203
PISSN: 01495992
EISSN: None
Source Type: Journal
DOI: 10.2337/diacare.20.4.469 Document Type: Note |
|
Times cited : (75)
|
|
References (0)
|
